news 2
Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO) published in the journal Nature Medicine.
Investigators create urine-based test to ID prostate cancers
Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine.
Can metabolic syndrome substantially increase Parkinson's risk?
As much as 31% of the world’s population has metabolic syndrome — a combination of several health issues, such as high blood pressure and abdominal obesity, that when blended can raise a person’s risk for several health conditions. Researchers found that people with metabolic syndrome were about 40% more likely to develop Parkinson’s disease than those without the condition.
9 Reasons You Might Have Brown Mucus (Phlegm)
Brown mucus, also called brown phlegm or sputum, is associated with a number of conditions, including chronic lung disease and infection with a virus or bacteria. It's commonly caused by old blood or inflammation in the lower portions of the throat and upper airways.
Combating cardiovascular disease: The simple, cost-effective test that saves lives
Routine testing for a specific lipoprotein known as Lp(a) would be a cost-saving way to significantly reduce the risk of cardiovascular disease and save lives, according to an international research taskforce led by Monash University.